Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of blood cells originating from somatically mutated hematopoietic stem cells, is common among the elderly and is associated with an increased risk of hematologic malignancies. We investigated the clinical, mutational, and transcriptomic characteristics in elderly Korean individuals with CHIP mutations. Methods: We investigated CHIP in 90 elderly individuals aged ≥60 years with normal complete blood counts at a tertiary-care hospital in Korea between June 2021 and February 2022. Clinical and laboratory data were prospectively obtained. Targeted next-generation sequencing of 49 myeloid malignancy driver genes and massively parallel RNA sequencing were performed to explore the molecular spectrum and transcriptomic characteristics of CHIP mutations. Results: We detected 51 mutations in 10 genes in 37 (41%) of the study individuals. CHIP prevalence increased with age. CHIP mutations were observed with high prevalence in DNMT3A (26 individuals) and TET2 (eight individuals) and were also found in various other genes, including KDM6A, SMC3, TP53, BRAF, PPM1D, SRSF2, STAG1, and ZRSR2. Baseline characteristics, including age, confounding diseases, and blood cell parameters, showed no significant differences. Using mRNA sequencing, we characterized the altered gene expression profile, implicating neutrophil degranulation and innate immune system dysregulation. Conclusions: Somatic CHIP driver mutations are common among the elderly in Korea and are detected in various genes, including DNMT3A and TET2. Our study highlights that chronic dysregulation of innate immune signaling is associated with the pathogenesis of various diseases, including hematologic malignancies.
Abstract
Background: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of blood cells originating from somatically mutated hematopoietic stem cells, is common among the elderly and is associated with an increased risk of hematologic malignancies. We investigated the clinical, mutational, and transcriptomic characteristics in elderly Korean individuals with CHIP mutations. Methods: We investigated CHIP in 90 elderly individuals aged ≥60 years with normal complete blood counts at a tertiary-care hospital in Korea between June 2021 and February 2022. Clinical and laboratory data were prospectively obtained. Targeted next-generation sequencing of 49 myeloid malignancy driver genes and massively parallel RNA sequencing were performed to explore the molecular spectrum and transcriptomic characteristics of CHIP mutations. Results: We detected 51 mutations in 10 genes in 37 (41%) of the study individuals. CHIP prevalence increased with age. CHIP mutations were observed with high prevalence in DNMT3A (26 individuals) and TET2 (eight individuals) and were also found in various other genes, including KDM6A, SMC3, TP53, BRAF, PPM1D, SRSF2, STAG1, and ZRSR2. Baseline characteristics, including age, confounding diseases, and blood cell parameters, showed no significant differences. Using mRNA sequencing, we characterized the altered gene expression profile, implicating neutrophil degranulation and innate immune system dysregulation. Conclusions: Somatic CHIP driver mutations are common among the elderly in Korea and are detected in various genes, including DNMT3A and TET2. Our study highlights that chronic dysregulation of innate immune signaling is associated with the pathogenesis of various diseases, including hematologic malignancies.
참고문헌 (31)
- Busque L, "Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis", Nat Genet, 44, pp.1179~1181 (2012)
- Xie M, "Age-related mutations associated with clonal hematopoietic expansion and malignancies", Nat Med, 20, pp.1472~1478 (2014)
- Steensma DP, "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes", Blood, 126, pp.9~16 (2015)
- Jaiswal S, "Age-related clonal hematopoiesis associated with adverse outcomes", N Engl J Med, 371, pp.2488~2498 (2014)
- Evans MA, "Cardiovascular disease, aging, and clonal hematopoiesis", Annu Rev Pathol, 15, pp.419~438 (2020)
- Jaiswal S, "Clonal hematopoiesis and nonhematologic disorders", Blood, 136, pp.1606~1614 (2020)
- Leoni C, "Dnmt3a restrains mast cell inflammatory responses", Proc Natl Acad Sci U S A, 114, pp.E1490~9 (2017)
- Zhang Q, "Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6", Nature, 525, pp.389~393 (2015)
- Jaiswal S, "Clonal hematopoiesis in human aging and disease", Science, 366, pp.eaan4673~ (2019)
- Zhong Yiming, "Application of Next Generation Sequencing in Laboratory Medicine", Annals of Laboratory Medicine, 41(1), pp.25~43 (2021), 대한진단검사의학회[DOI]
- Park Hee Sue, "Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing", Annals of Laboratory Medicine, 42(5), pp.602~605 (2022), 대한진단검사의학회[DOI]
- Dobin A, "STAR : ultrafast universal RNA-seq aligner", Bioinformatics, 29, pp.15~21 (2013)
- Love MI, "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", Genome Biol, 15, pp.550~ (2014)
- Mi H, "PANTHER version 16 : a revised family classification, tree-based classification tool, enhancer regions and extensive API", Nucleic Acids Res, 49, pp.D394~403 (2021)
- Fabregat A, "Reactome diagram viewer : data structures and strategies to boost performance", Bioinformatics, 34, pp.1208~1214 (2018)
- Subramanian A, "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
- Cuartero S, "Towards a better understanding of cohesin mutations in AML", Front Oncol, 9, pp.867~ (2019)
- Viny AD, "Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC Self-renewal and differentiation", Cell Stem Cell, 25, pp.682~696 (2019)
- Cuartero S, "Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation", Nat Immunol, 19, pp.932~941 (2018)
- Thota S, "Genetic alterations of the cohesin complex genes in myeloid malignancies", Blood, 124, pp.1790~1798 (2014)
- Cancer Genome Atlas Research Network, "Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia", N Engl J Med, 368, pp.2059~2074 (2013)
- Welch JS, "The origin and evolution of mutations in acute myeloid leukemia", Cell, 150, pp.264~278 (2012)
- Thol F, "Mutations in the cohesin complex in acute myeloid leukemia : clinical and prognostic implications", Blood, 123, pp.914~920 (2014)
- Barreyro L, "Chronic immune response dysregulation in MDS pathogenesis", Blood, 132, pp.1553~1560 (2018)
- Mantovani A, "Neutrophils in the activation and regulation of innate and adaptive immunity", Nat Rev Immunol, 11, pp.519~531 (2011)
- Rawat K, "Neutrophil-derived granule cargoes : paving the way for tumor growth and progression", Cancer Metastasis Rev, 40, pp.221~244 (2021)
- Filep JG, "Targeting neutrophils for promoting the resolution of inflammation", Front Immunol, 13, pp.866747~ (2022)
- Liew PX, "The neutrophil’s role during health and disease", Physiol Rev, 99, pp.1223~1248 (2019)
- Jaiswal S, "Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease", N Engl J Med, 377, pp.111~121 (2017)
- Kiefer KC, "Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality", ESC Heart Fail, 8, pp.1873~1884 (2021)
- van Zeventer IA, "Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals", Blood, 135, pp.1161~1170 (2020)